G-CSF infusion for thin uterine lining
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether infusing a growth factor (G-CSF) into the uterus can help women with a thin uterine lining (≤7 mm) before embryo transfer. The goal is to improve pregnancy chances.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old.
- Your ovaries work normally (you have regular periods or hormone levels in a normal range).
- In a past cycle, your uterine lining was thin (7 mm or less).
- You have at least two good-quality frozen embryos left.
- You have tried embryo transfer 2 or fewer times before.
- You are not allergic to G-CSF (a medication used to boost white blood cells).
- You do not have uterine problems like fibroids that change the shape of the cavity, severe adenomyosis, or untreated scars inside the uterus.
- You do not have current or past pelvic cancer or have had radiation or chemotherapy.
- You are not in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using stem cell particles (exosomes) to help rebuild the lining of the womb in women whose lining is too thin after surgery for scar tissue. It may improve chances of success with IVF.
This trial tests whether injecting platelet-rich plasma (a concentrate from your own blood) into the uterus or ovaries can help women with certain fertility issues, such as damaged uterine lining, scarring, or low egg reserve. It aims to improve pregnancy chances in these challenging cases.
This trial studies whether platelet-rich plasma (PRP) can help grow a thin uterine lining enough to support a pregnancy. It is aimed at people who have had repeated unsuccessful frozen embryo transfers and had a lining of 6 mm or less.
This trial tests a new treatment for people with a thin uterine lining or uterine scarring that hasn't responded to other stem cell therapy. It might help improve the lining so pregnancy is possible.
This study tests whether G-CSF (a medicine that helps the immune system) given during IVF can reduce miscarriages in women who have had repeated pregnancy losses with no clear reason.
This study tests if a special treatment made from cord blood can help women with a thin uterine lining (the inner layer of the womb) or Asherman syndrome (scar tissue). The goal is to see if it can improve the lining so it's healthier for pregnancy.
Hear when a new Thin Endometrium trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.